SCHEMBL7779719

SCHEMBL7779719

Cc1cc2c(cc1F)NC(=O)CN2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.38
CYP11B2 P19099 2/20 0.38
PKM P14618 4/20 0.36
DAPK3 O43293 1/20 0.36
NTRK1 P04629 1/20 0.36
PIM1 P11309 1/20 0.36
FLT3 P36888 1/20 0.36
GSK3B P49841 1/20 0.36
ROCK1 Q13464 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
POLB P06746 1/20 0.35
IDO1 P14902 1/20 0.35
BRD4 O60885 1/20 0.34
CREBBP Q92793 1/20 0.34
SMYD3 Q9H7B4 2/20 0.33
HPGD P15428 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DAO P14920 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14361898 0.87 CYP11B1 (0.42) CYP11B1CYP11B2CREBBPSMYD3
SCHEMBL17348364 0.87 CYP11B1 (0.42) CYP11B1CYP11B2POLBSMYD3HPGD
SCHEMBL25414934 0.79 TSHR (0.40) CYP11B1CYP11B2PKMMAPK1
SCHEMBL29338764 0.79 TSHR (0.40) CYP11B1CYP11B2PKMMAPK1
SCHEMBL7784162 0.79 BCHE (0.46) CYP11B1CYP11B2PKMPOLBSMYD3
SCHEMBL7779880 0.79 CYP11B1 (0.38) CYP11B1CYP11B2PKMIDO1BRD4
SCHEMBL7784637 0.79 CYP11B1 (0.38) CYP11B1CYP11B2IDO1SMYD3MAPK1
SCHEMBL7786893 0.79 CYP11B1 (0.38) CYP11B1CYP11B2IDO1SMYD3MAPK1
SCHEMBL7786783 0.79 CYP11B1 (0.38) CYP11B1CYP11B2PKMIDO1BRD4
SCHEMBL7779695 0.79 GRIN2D (0.39) CYP11B1CYP11B2PKMPOLBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251903-B1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist COCENSYS, INC. 2001-06-26 US disclosed
US-6147075-A ANALGESICS; PSYCHOLOGICAL DISORDERS COCENSYS, INC. (US) 2000-11-14 US disclosed
EP-0732942-A4 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS COCENSYS INC (US) 2000-03-22 EP disclosed
US-5977107-A Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists COCENSYS, INC. (US) 1999-11-02 US disclosed
US-5631373-A NERVOUS SYSTEM DISORDERS STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-05-20 US disclosed
EP-0732942-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1996-09-25 EP disclosed
WO-1995012417-A1 ALKYL, AZIDO, ALKOXY, AND FLUORO-SUBSTITUTED AND FUSED QUINOXALINEDIONES AND THE USE THEREOF AS GLYCINE RECEPTOR ANTAGONISTS ACEA PHARMACEUTICALS, INC. (US) 1995-05-11 WO disclosed